Kairos Ventures portfolio company Axial Biotherapeutics announced the appointment of Dr. Gregory T. Bates as Senior Vice President of...

Read more

We're excited to share that our portfolio company, Axial Biotherapeutics, has been selected as one of FierceBiotech's Fierce 15...

Read more

This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

Axial Biotherapeutics today announced the launch of the Company with a $19.15 million Series A round of financing. The...

Read more